We are live on ! Find out more
AMRX icon

Amneal Pharmaceuticals
AMRX

156 hedge funds and large institutions have $202M invested in Amneal Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 48 increasing their positions, 47 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.51% more ownership

Funds ownership: 65.78% → 67.29% (+1.5%)

1% more funds holding

Funds holding: 154 → 156 (+2)

7% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 27

2% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 47

1% more capital invested

Capital invested by funds: $200M → $202M (+$2.4M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

20% less call options, than puts

Call options by funds: $119K | Put options by funds: $149K

Holders
156
Holders Change
+2
Holders Change %
+1.3%
% of All Funds
2.51%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
29
Increased
48
Reduced
47
Closed
27
Calls
$119K
Puts
$149K
Net Calls
-$30K
Net Calls Change
+$656K

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$8.55M
2
Millennium Management
Millennium Management
New York
+$6.8M
3
Norges Bank
Norges Bank
Norway
+$6.08M
4
AQR Capital Management
AQR Capital Management
Connecticut
+$2.61M
5
Bank of America
Bank of America
North Carolina
+$1.96M

Top Sellers

1
TGA
TPG GP A
Texas
-$8.71M
2
EP
Eversept Partners
New York
-$8.65M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$5.55M
4
Citadel Advisors
Citadel Advisors
Florida
-$2.14M
5
JAM
Jupiter Asset Management
United Kingdom
-$1.98M
Name Holding Trade Value Shares
Change 		Change in
Stake
Mackenzie Financial
101
Mackenzie Financial
Ontario, Canada
$55.9K +$63K +28,106 New
ASRS
102
Arizona State Retirement System
Arizona
$55.3K +$2.54K +1,132 +4%
KAS
103
Kestra Advisory Services
Texas
$54.3K +$3.3K +1,471 +6%
PGFC
104
Peapack-Gladstone Financial Corp
New Jersey
$46K -$672 -300 -1%
Squarepoint
105
Squarepoint
New York
$45.9K +$51.7K +23,057 New
DTL
106
Dynamic Technology Lab
Singapore
$44K +$49.3K +21,976 New
Zurich Cantonal Bank
107
Zurich Cantonal Bank
Switzerland
$43.9K +$34.6K +15,454 +235%
TLP
108
Tri Locum Partners
New York
$43K +$48.5K +21,622 New
Janus Henderson Group
109
Janus Henderson Group
United Kingdom
$39.2K -$44.2K -19,739 -50%
Public Employees Retirement Association of Colorado
110
Public Employees Retirement Association of Colorado
Colorado
$39K – – –
UBS Group
111
UBS Group
Switzerland
$37.8K -$17K -7,592 -29%
SAM
112
Shell Asset Management
Netherlands
$35K -$84.9K -37,869 -68%
T. Rowe Price Associates
113
T. Rowe Price Associates
Maryland
$35K +$1.18K +525 +3%
EGM
114
Engineers Gate Manager
New York
$34.1K +$38.4K +17,112 New
SEI Investments
115
SEI Investments
Pennsylvania
$33K -$1.44K -642 -4%
AB
116
Amalgamated Bank
New York
$33K – – –
Lazard Asset Management
117
Lazard Asset Management
New York
$33K – – –
Bank of Montreal
118
Bank of Montreal
Ontario, Canada
$31K +$29.8K +13,296 New
American Century Companies
119
American Century Companies
Missouri
$30.2K +$34K +15,166 New
ProShare Advisors
120
ProShare Advisors
Maryland
$26.4K +$4.26K +1,900 +17%
PCM
121
Prelude Capital Management
New York
$25K +$28.2K +12,562 New
PMEF
122
Point72 Middle East FZE
United Arab Emirates
$23.5K +$26.5K +11,832 New
OSAM
123
O'Shaughnessy Asset Management
Connecticut
$23.3K -$1.22K -542 -4%
Verition Fund Management
124
Verition Fund Management
Connecticut
$23.1K +$26K +11,600 New
SF
125
Synovus Financial
Georgia
$20.3K -$11.2K -5,000 -33%
3 4
5
6 7

AMRX Hedge Fund Activity: Q4 2022 in Review

156 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Amneal Pharmaceuticals (AMRX) for Q4 2022, worth a combined $202M — up 1.2% from $200M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new AMRX positions and 27 closed out — a net gain of 2 holders — while 48 added to existing stakes and 47 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $8.55M. The largest seller was TPG GP A, cutting an estimated $8.71M.

  • 156 institutional investors held Amneal Pharmaceuticals (AMRX) as of Q4 2022, up from 154 in Q3 2022.
  • Funds reported $202M of Amneal Pharmaceuticals stock for Q4 2022, up 1.2% quarter-over-quarter.
  • 29 funds opened new Amneal Pharmaceuticals positions in Q4 2022 and 27 closed out, a net change of +2 holders.
  • The largest Amneal Pharmaceuticals buyer in Q4 2022 was Morgan Stanley, an estimated $8.55M added.
  • The largest Amneal Pharmaceuticals seller in Q4 2022 was TPG GP A, an estimated $8.71M sold.

Based on aggregated 13F filings for Q4 2022.